Simmons & Simmons advises RevoluGen on global distribution agreement with Merck KGaA
02 Jul 2019
Simmons & Simmons has advised RevoluGen on a global distribution agreement for its Fire Monkey / Fire Flower product with Merck KGaA. The product is a kit that can be used for purification of DNA for long-read sequencing applications, utilising its reliable, rapid, user friendly protocol, or for DNA size selection.
Under the terms of the agreement, RevoluGen remains the manufacturer of the product, with Merck acquiring the non-exclusive rights for worldwide distribution of the Fire Monkey / Fire Flower product.
The Simmons & Simmons team which advises RevoluGen is led by Corporate partner Charles Mayo and comprises Oli Gingell (Corporate), Audrey Williams and Roisin Murphy (Employment), Tair Hussain (Incentives) and on IP and this transaction by IP partner Richard Binns, supported by supervising associate James Agnew.
Relationship partner Charles Mayo commented: “High quality, long read DNA sequencing helps enable identification of diseases and the development of treatments and diagnostics for them on a personalised basis, contributing to the development of precision medical outcomes for patients. We are delighted to act for RevoluGen and on this collaboration between an early stage company with Merck, one of the largest global companies in the healthcare and life sciences sector.”
RevoluGen is a small, UK based molecular chemistry research and development company that specialises in High Molecular Weight DNA isolation and purification from cell samples specifically for long-read sequencing applications.
LinkedIn | Twitter